Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1489-1492

  Sanaee, M S ^a   O'Byrne, P M ^a   Nair, P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ASTHMA; BLOOD CELL COUNT; CASE REPORT; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; HYPERPLASIA; LETTER; LOEFFLER PNEUMONIA; PRICK TEST; PRIORITY JOURNAL; SPIROMETRY; THORAX RADIOGRAPHY; TUBERCULIN TEST;

AGED; ASTHMA; EOSINOPHILS; FEMALE; HUMANS; HYPERPLASIA; LUNG; LUNG DISEASES; NEUROSECRETORY SYSTEMS; PULMONARY EOSINOPHILIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 73249118080     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00109409     Document Type: Letter

References (19)

1. Celli BR, MacNeeW, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
2. BusseWW, Lemanske RF. Asthma. N Engl J Med 2001; 344: 350-362.
3. Berry MA, Hargadon B, McKenna S, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005; 35: 598-601.
4. Pizzichini MM, Pizzichini E, Parameswaran K, et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999; 6: 323-330.
5. Armas OA, White DA, Erlandson RA, et al. Diffuse idiopathic pulmonary neuroendocrine proliferation presenting as interstitial lung disease. Am J Surg Pathol 1995; 19: 963-970.
6. Ge Y, Eltorky MA, Ernst RD, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Ann Diag Pathol 2007; 11: 122-126.
7. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-1068.
8. Swigris J, Ghamande S, Rice TW, et al. Diffuse idiopathic neuroendocrine cell hyperplasia: an interstitial lung disease with airway obstruction. J Bronchol 2005; 12: 62-65.
9. Aguayo SM, Miller YE, Waldron Jr JA, et al. Idiopathic hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992; 327: 1285-1288.
10. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007; 62: 248-252.
11. Hargreave FE, Parameswaran K. Asthma, COPD and bronchitis are just components of airway diseases. Eur Respir J 2006; 28: 264-267.
12. Marchand E, Cordier JF. Idiopathic chronic eosinophilic pneumonia. Sem Resp Crit Care Med 2006; 27: 134-141.
13. Parameswaran K, Hargreave FE. The use of sputum cell counts to evaluate asthma medications. Br J Clin Pharmacol 2001; 52: 121-128.
14. Solway J, Leff AR. Sensory neuropeptides and airway function. J Appl Physiol 1991; 71: 2077-2087.
15. O'Connor TM, O'Connel J, O'Brien DI, et al. The role of substance P in inflammatory disease. J Cell Phys 2004; 201: 167-180.
16. Springer J, Geppetti P, Fischer A, Groneberg DA. Calcitonin generelated peptide as inflammatory mediator. Pulmonary Pharm Therapeutics 2003; 16: 121-130.
17. Joos GF, De Swert KO, Schelfhout V, et al. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann NY Acad Sci 2003; 992: 218-230.
18. Joos G, Pauwels R, Van Der Straten M. The effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 1987; 42: 779-783.
19. Wiedermann FJ, Kahler CM, Reinisch N, et al. Induction of normal human eosinophil migration in vitro by substance P. Acta Haematol 1993; 89: 213-215.